small cap « AGORACOM Small-cap Investor Relations Blog

Posts Tagged ‘small cap’

ImagineAR $IP.ca $IPNFF and The Pittsburgh Gateways Corporation Sign MOU To Integrate Augmented Reality Into the Energy Innovation Center $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 7:04 AM on Thursday, August 13th, 2020

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Announced the signing of an MOU with the Pittsburgh Gateways Corporation, a developer of technology-based research centers in the United States
Since its inception, Gateways has established, or formed collaborative alliances with, over 30 technology centers, primarily in Western Pennsylvania, but extending throughout the Northeastern and Midwestern United States
The organization has also assisted in the formation of over 60 new or development-stage ventures, many of which are thriving today as successful business and economic development enterprises. Its efforts have contributed to the creation of thousands of jobs.

VANCOUVER, BC and ERIE Pa., Aug. 13, 2020 ImagineAR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) an Augmented Reality Company that enables sports teams, businesses, retailers and organizations to instantly create their own AR mobile campaigns, is pleased to announce the signing of an MOU with the Pittsburgh Gateways Corporation (“Gateways”), a developer of technology-based research centers in the United States.

Since its inception, Gateways has established, or formed collaborative alliances with, over 30 technology centers, primarily in Western Pennsylvania, but extending throughout the Northeastern and Midwestern United States. The organization has also assisted in the formation of over 60 new or development-stage ventures, many of which are thriving today as successful business and economic development enterprises. Its efforts have contributed to the creation of thousands of jobs.

Pittsburgh Gateways Corporation CEO Robert Meeder stated: “As an economic development organization, we focus on integrating advanced immersive technology such as augmented reality into our center as well as introducing it to our tenants. ImagineAR is a leader in the mobile augmented reality in the North America and we are truly excited to partner with them and drive new AR engagements and revenue together. The applications of ImagineAR into our Energy Innovation Center will be extensive.”

Gus Frerotte, 15 year NFL Pro Bowl QB and Developer/Coordinator of Media and Communications Operations at the EIC, added “From the first moment I set foot in the EIC I knew I wanted to be part of this team. I admire the leadership of Pittsburgh Gateways Corporation and their mission for the EIC. The EIC is a robust intersection of research, training and community service and my goal is to help with the application of my skills and experience in communications and the development of human performance tools. When I first spoke with Neal Bendesky, VP Sports & Events of ImagineAR Inc., I knew that the EIC would benefit from this collaboration. I am excited for the future as the EIC and its partners come to life.”

ImagineAR CEO Paul Silverrstieen added: “We are honored to be selected as the Augmented Reality Platform Solution for the prestigious Gateways organization. Their reputation as a leader in the energy sector as well as high-tech incubators, provides ImagineAR the opportunity to work with energy and entrepreneurial companies to create AR engagements and activations together. This partnership is expected to develop a new sector revenue channel for ImagineAR. “

About Pittsburgh Gateways Corporation

Pittsburgh Gateways Corporation’s mission is to provide strategic planning, development and direct management assistance for communities, community-based economic development organizations, research & academic institutions, and private entities seeking the acceleration of technology-based businesses. Incorporated into this mission is our goal to combat community deterioration in the City of Pittsburgh and other economically distressed areas of Pennsylvania. Pittsburgh Gateways Corporation is registered as a 501(c)(3) non-profit organization. The website is https://www.pghgateways.org/.

About ImagineAR

ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, (products, landmarks and more to instantly engage videos, information, advertisements, coupons,3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies. The AR Platform is available as an SDK Plug-in for existing mobile apps.

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

For more information or to explore working with Imagination Park, please email [email protected], or visit www.imagineAR.com.

All trademarks of the property of respective owners.

ON BEHALF OF THE BOARD

Alen Paul Silverrstieen
President & CEO
(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc

We encourage you to do your own due diligence and ask your broker if Imagination Park Entertainment Inc. (cse: IP) is suitable for your particular investment portfolio*.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by ImagineAR’s management. Although Imagine AR Inc. believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Imagine AR Inc. can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR Inc. disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE ImagineAR

Tags: AR, augmented reality, Chelsea APPS Factory, CSE, small cap, stocks, tsx
Posted in Imagine AR | Comments Off on ImagineAR $IP.ca $IPNFF and The Pittsburgh Gateways Corporation Sign MOU To Integrate Augmented Reality Into the Energy Innovation Center $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Datametrex $DM.ca Secures COVID-19 Antigen Detection Kits

Posted by AGORACOM-JC at 9:10 AM on Wednesday, August 12th, 2020

Announced that it has secured rights to sell and distribute South Korean manufacturer PCL, Inc.’s (“PCL”) COV05 COVID19 Rapid Antigen Detection Kits
These test kits are suitable for point of care tests. No extra equipment is needed. They are easy to use with over 97% accuracy, and results are available in 5 to 10 minutes
Antigen Rapid Diagnosis Kit developed by PCL is a method of fluorescently measuring the presence of a COVID-19 infection

TORONTO, Aug. 12, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured rights to sell and distribute South Korean manufacturer PCL, Inc.’s (“PCL”) COV05 COVID19 Rapid Antigen Detection Kits. These test kits are suitable for point of care tests. No extra equipment is needed. They are easy to use with over 97% accuracy, and results are available in 5 to 10 minutes.

The Antigen Rapid Diagnosis Kit developed by PCL is a method of fluorescently measuring the presence of a COVID-19 infection. It is an in-vitro diagnostic medicaldevice to detect the SARS-CoV-2 antigen from a person’s oropharyngeal and nasopharyngeal secretions if the specimen contains antigens to SARS-CoV-2, a colored line appears in the T line area.

View the PCL test by clicking the link PCL COVID-19 ANTIBODY TEST – COV0

“According to the manufacturer, PCL, this test can detect antigens of COVID-19 from a swab in the nose or throat and provide results in 10 minutes with over 97% accuracy,” said Marshall Gunter, CEO of Datametrex. “These almost-instant kits can be easily used at home. With the rise of cases in the United States and throughout the world, we at Datametrex believes it is critical to test and protect.”

PCL states that the clinical sensitivity (confirmed the actual positive of the approved person) is 100% and the clinical specificity (confirmed the actual negative of the negative person) is 97.78%. Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.

The following certifications have been awarded to these PCL Antigen Test Kits: CE Certificate, Korea FDA, FIND Listed, UNGM Supplier. Countries includes the EU, 2 countries in the Middle East- Qatar and UAE, India, Russia, 3 countries in Latin America- Guatemala, Ecuador, and Colombia.

The PCL Antigen Detection kit has the CE Certificate meaning that the manufacturer and products have met EU declaration of standards for health, safety, and environmental protection, allowing this product to be sold within the 22 countries in the European Economic Area.

Worldwide, currently there have been over 19.7M people who have been tested positive for COVID-19 but the actual case count is believed to be higher, as a significant number of asymptomatic people may not have been tested. Even more worrying is that most families have had to wait more than 72 hours for their test results to come back from both public and private labs increasing the possibility of spreading the virus.

Rapid Diagnosis Kit is easy when there are no symptoms even after COVID-19 infection, or when ‘positive’ and ‘negative’ are not evident in tests such as RT-PCR. When an infection occurs, an antigen against COVID-19 is formed in the body after some time, so it is a post-test that is essential as a preventive measure.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time. Health Canada must approve these COVID-19 test kits before they can be used in Canada. The Company plans to sell these kits in all countries where the kits have been approved for sale.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

View the PCL test by clicking the link PCL COVID-19 ANTIBODY TEST – COV0

About Datametrex

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements

Tags: AI, Antigen Rapid Diagnosis, bot, covid19, CSE, datametrex, investments, PCL, small cap
Posted in All Recent Posts, Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Secures COVID-19 Antigen Detection Kits

Else Nutrition $BABY.ca Announces North American Launch of World’s Only Real Alternative to Dairy-Based Baby Nutrition $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:22 AM on Tuesday, August 11th, 2020

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Baby Nutrition Paradigm shift: After 120 years, Else introduces a completely novel protein source for baby nutrition (over one year old) with a breakthrough, clean and sustainable production process.
Globally patented, and founded by infant nutrition industry veterans, Else Nutrition is the first dairy and soy- free, clean label, plant-based complete nutrition for babies (1 year and over).
A Revolution in the way babies are fed, Else Nutrition offers parents a great- tasting, dairy-free, soy-free and GMO-free alternative.
Else Plant-Based Complete Nutrition is now available for purchase at elsenutrition.com, U.S. shipping nationwide and to Canada.

VANCOUVER, BC / August 11, 2020 / ELSE NUTRITION HOLDINGS INC. (TSX-V:BABY) (OTCQX:BABYF) (FSE:0YL) (“Else” or the “Company“), today announces the online product launch of its Else Plant-Based Complete Toddler Nutrition, the first fully certified USDA Organic, Clean Label, Plant-Based, Soy-Free nutritional drink for toddlers. Made with ingredients, vitamins and minerals that help support growth and development after a baby’s first year. Else Plant-Based Complete Nutrition is the only globally-patented, real alternative for babies beyond the first year – including those with milk intolerances/sensitivities, those looking to avoid dairy and soy, and for all families looking for a clean, plant-based option for their children

Dairy-free, soy-free, corn syrup-free, gluten-free and non-GMO, Else Nutrition is a unique globally patented combination of whole-plant organic ingredients – almonds buckwheat and tapioca. This combination meets the gold standard equivalent of human milk nutritional composition values, based on WHO international standards, among others. Else Plant- Nutrition meets the strictest regulatory requirements and the highest nutrition standards, providing a full essential amino acid profile and a clean source of protein. It is manufactured in an infant grade U.S. manufacturing site and endorsed by a board of leading U.S. and international pediatricians and nutritionists.

“We are thrilled that today marks a huge leap forward in plant-based alternatives in the baby and toddler category,” said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. “For more than 120 years, cow’s milk and soy have dominated. After seven years of R&D, we are finally able to offer something else to parents and bring a real, clean label alternative to families across North America, so that they will never have to compromise on the health and nutrition of their toddler again.”

Else Plant-Based Complete Nutrition for Toddlers is minimally processed. Else intends for all its future products to meet this standard. With more than seven years of research and development, Else’s breakthrough process creates nutrition products from whole plants without altering their chemistry or using highly-processed extracts, or harsh chemicals. Through this disruptive process, Else is able to maximize the nutritional value and minimize environmental impact.

Additionally, Else Nutrition’s innovation pipeline includes a breakthrough, plant-based, clean label infant formula for babies 0-12 months. It is anticipated to launch in approximately two years, currently on its pathway for final FDA approval.

Beyond the brand’s Advisory Board of Pediatricians and nutritionists, Else has already captured the attention of many influential mothers, such as Hilaria Baldwin. As a mother of four with the fifth on the way, Hilaria came across Else as she searched for nutrition products for her toddler Romeo. After using the product, Hilaria decided to partner with Else to support its product launch.

Else Plant-Based Complete Nutrition for Toddlers is now available at elsenutrition.com, currently priced at $36 for a single 22 oz. powder canister and $136 for a 4-pack. The product will also be offered on Amazon.com later this month and in select retail chains sometime during Q4 2020.

Disruptive, ‘Beyond Organic’ Production Process

Else products are minimally processed, using the cleanest production process in the infant nutrition industry. Else’s ‘Beyond Organic’ disruptive manufacturing process transforms whole plants to tasty toddler nutrition, without using highly-processed extracts or derivatives, harsh chemicals, or high-fructose corn syrup. Changing only the texture of the plants, and never the fundamental chemistry, allowing for more of the nutrients that nature intended to nourish the child.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

Media Contact:

Covet Consumer Business Unit
Gianna Totaro
[email protected]
P: 1-301-875-6574

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will,” “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Tags: baby food, CSE, investing, organic, small cap, stocks, tsx
Posted in Else Nutrition Holdings Inc., Featured | Comments Off on Else Nutrition $BABY.ca Announces North American Launch of World’s Only Real Alternative to Dairy-Based Baby Nutrition $KMB $BMY $ABT $WYE

Hollister Biosciences $HOLL.ca Closes $1.5 Million Private Placement Financing $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 8:11 PM on Monday, August 10th, 2020

https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1

Announced non-brokered private placement financing by issuance of 17,646,889 units at a price of $0.085 per Unit for gross proceeds of approximately $1,500,000

VANCOUVER, BC, Aug. 10, 2020 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 230 dispensaries throughout California and over 80 dispensaries throughout Arizona, is pleased to announce that it has closed its previously announced non-brokered private placement financing by issuance of 17,646,889 units (the “Units” and each individually, a “Unit“) at a price of $0.085 per Unit for gross proceeds of approximately $1,500,000 (the “Offering“).

Each Unit is comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant. Each warrant will be exercisable into Share at a price of $0.10 until August 10, 2022.

The Company has paid eligible finders cash commission in the total amount of $108,201.26. The Company has also issued non-transferable compensation options (“Finder’s Options“) to finders to acquire up to a total of 1,272,959 Units (“Finder’s Units“), at a price of $0.085 per Finder’s Unit on or before August 10, 2022. Each Finder’s Unit will consist of one Share and one non-transferable share purchase warrant (the “Finder’s Warrant“). Each Finder’s Warrant will entitle the holder to purchase one Share at a price of $0.10 per Share on or before August 10, 2022.

All securities issued in connection with the Offering are subject to a statutory hold period of four-months and one day ending on December 11, 2020. The Company intends to use the net proceeds of the Offering for the expansion of Venom Extracts, Hollister’s 100% owned subsidiary, into California and for working capital and general corporate purposes.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

The CSE does not accept responsibility for the adequacy or accuracy of this release.

The securities issued in connection with the Offering have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “1933 Act“), or under any state securities laws, and may not be offered or sold, directly or indirectly, or delivered within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the 1933 Act) absent registration or an applicable exemption from the registration requirements. This news release does not constitute an offer to sell or a solicitation to buy such securities in the United States.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

Tags: budder, Cannabis, CBD, CSE, hash, hashbone, Hemp, mushrooms, pre-roll, small cap, tsx
Posted in Hollister Biosciences | Comments Off on Hollister Biosciences $HOLL.ca Closes $1.5 Million Private Placement Financing $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

VIDEO – ImagineAR $IP.ca $IPNFF Adds Media Powerhouse Michael Anderson To Spearhead UK & Euro Sales $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 4:30 PM on Thursday, August 6th, 2020

If you were a small cap Augmented Reality company from Vancouver that needed to appoint an old media / new media powerhouse to head up your European sales operations, we really don’t think you could have found someone better credentialed than Michael Anderson – and that’s exactly what ImagineAR (IP:CSE) (IPNFF:OTCQB) did.

Anderson is a highly regarded leader in the world of digital with his roots firmly based in UK media. Part entrepreneur, part corporate animal, he quickly rose through the ranks ending up as Managing Director of News UK. He worked for Rupert Murdoch and Les Hinton during his rise to the top and made the Board room of both News UK and Associated Newspapers (publishers of the Daily Mail).

Sensing the changing winds of the media business, Anderson was a driving force on the launch team of Metro, which overtook The Sun in 2018 as the largest circulation of any newspaper in the UK. At Metro, he was instrumental in the paper being cited as a new business case with commercial results not seen previously in the newspaper industry, growing revenue from £100k a week to £1m per week in just 12 months. Additionally, Mike was the founder of the Chelsea APPS Factory which included UK clients KPMG, Ladbrokes, Standard Life, TfL, Vanquis and Waitrose.

….. And now he is sensing another change in the winds to put his considerable talents and team behind the Augmented Reality solutions of ImagineAR.

If you don’t know what Augmented Reality (AR) is, this quote from Apple CEO Tim Cook is all the motivation you need to get up to speed:

“AR Will play an important role in how we use technology in the future – and promises to be as influential in our society as the smart phone”

Anderson wholeheartedly agrees, stating “ImagineAR is the most advanced AR platform in the market today and I am excited to launch the company’s sales and marketing initiatives in the UK and Europe.”

That quote is just the tip of the iceberg. Watch what Anderson has to say about the “unlimited possibilities of Augmented Reality” and some pretty good hints about whose doors he will be knocking on first …. which is pretty impressive given the fact August is vacation season in Europe 🙂

If our interview with CEO Alen Paul Silverrstieen and Michael Anderson is any indication, it sounds like the Company’s growth into the UK and Europe is all but assured in 2020 and well beyond.

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

Tags: AR, augmented reality, Chelsea APPS Factory, CSE, small cap, stocks, tsx, tsx-v
Posted in AGORACOM Via Satellite, Featured, Imagine AR | Comments Off on VIDEO – ImagineAR $IP.ca $IPNFF Adds Media Powerhouse Michael Anderson To Spearhead UK & Euro Sales $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Else Nutrition $BABY.ca Provides Corporate Update $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 1:02 PM on Thursday, August 6th, 2020

Company’s proprietary, plant based, clean label formula for toddlers will launch in August 2020
A full-scale marketing campaign for the launch has commenced with samples and pre-order sales over the past few weeks; the product will be shipped to consumers in the U.S. and Canada from two U.S. based warehouses of a third-party logistics partner
The Company’s Amazon.com store will launch in the coming weeks

VANCOUVER, BC /August 6, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition, is pleased to provide the following corporate update.

“Our team has been working relentlessly, during an unprecedently difficult time, to bring our product to market. As we get set to launch, we are beyond thrilled to have crossed major hurdles over the past months and weeks – including full scale manufacturing with a U.S. based partner and mobilization of our U.S. supply chain which has culminated in our ability to ship samples of our plant-based formula for toddlers to eager parents across North America,” said Ms. Hamutal Yitzhak, CEO and Co-Founder of Else.

North America Launch

The Company’s proprietary, plant based, clean label formula for toddlers will launch in August 2020. A full-scale marketing campaign for the launch has commenced with samples and pre-order sales over the past few weeks; the product will be shipped to consumers in the U.S. and Canada from two U.S. based warehouses of a third-party logistics partner. The Company’s Amazon.com store will launch in the coming weeks.

U.S. Manufacturing

The first full-scale commercial manufacturing run of the toddler nutrition powder product was successfully completed by the Company’s U.S. manufacturing partner and packed at a co-packer plant in Nevada.

The terms of the U.S. manufacturing agreement have been negotiated and a formal agreement will be executed upon the receipt of final yield and cost optimization parameters. The next commercial manufacturing run is booked and secured.

FDA Regulatory Pathway

The Company in conjunction with its FDA consulting partner continues to progress on the regulatory pathway for multiple products including an infant formula and new products currently in development for the adult nutrition market.

Health and Happiness International Holdings Limited

The Company’s negotiations with its strategic partner, H&H Global, for distribution rights of the toddler and infant formula in France are advancing well. The parties are studying the target market needs, channels, and regulations, in addition to preparing a launch plan and negotiating the distribution terms. Additionally, discussions regarding distribution in additional markets have also commenced.

Cash and Runway

The company is well capitalized, with approximately CAD$7.0 million in cash, and no short or long-term debt, to fully support its manufacturing and go-to-market plans for the next 12 months.

About Else Nutrition Holdings Inc.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

TSX Venture Exchange

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Tags: baby food, CSE, investing, organic, small cap, stocks, tsx, tsx-v
Posted in Else Nutrition Holdings Inc., Featured | Comments Off on Else Nutrition $BABY.ca Provides Corporate Update $KMB $BMY $ABT $WYE

Datametrex $DM.ca Commenced Rolling Out COVID-19 Screening Solutions in Anticipation of P.O. From Educational Organizations

Posted by AGORACOM-JC at 9:10 AM on Wednesday, August 5th, 2020

Commenced rolling out its screening solutions for health and safety in the education sector in anticipation of Purchase Order from schools and international student recruiting agencies by launching of the new COVID-19 pre-screening and screening tools
As the current pandemic continues to impact our world, education is one of the most hit industry
With schools plan to reopen in September, Datametrex is offering solutions to educational organizations for the health and safety of students, teachers, and administrative staff

TORONTO, Aug. 05, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) – Through its COVID-19 screening solutions, Datametrex has commenced rolling out its screening solutions for health and safety in the education sector in anticipation of Purchase Order from schools and international student recruiting agencies by launching of the new COVID-19 pre-screening and screening tools.

As the current pandemic continues to impact our world, education is one of the most hit industry. With schools plan to reopen in September, Datametrex is offering solutions to educational organizations for the health and safety of students, teachers, and administrative staff. A recent article by the CBC mentioned that language and private schools are struggling to survive the pandemic because they depend on international students coming into Canada. There are roughly 200 language schools across the country, with 40,000 international students in attendance. With the tools available by Datametrex, these organizations could pre-screen, screen, and report on exposures to decrease the spread and mitigate the risk. (https://www.cbc.ca/news/business/language-schools-covid-foreign-students-1.5668592)

“With schools poised to reopen in Fall, we offer important tool to the education industry. Key is not only opening up the school but also maintaining schools to stay open,” said Marshall Gunter, CEO of Datametrex. “With our pre-screening and screening tools, educational organizations can now provide a safer academic environment to the students and safer workplace to teaching staff with rapid results and trends for COVID-19 in real-time.”

These tools were developed as a direct response to customer needs and the ever-changing physical distancing recommendations, safety guidelines, and workplace flexibility initiatives being observed across North America and around the globe.

About Datametrex
Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements

Tags: AI, bot, covid19, CSE, datametrex, investments, small cap
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Commenced Rolling Out COVID-19 Screening Solutions in Anticipation of P.O. From Educational Organizations

Hollister Biosciences Inc. $HOLL.ca and Heavy Brands Inc. Enter into Letter of Intent for Proposed Joint Venture Agreement $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 8:16 AM on Wednesday, August 5th, 2020

Announced that it’s entered into a letter of intent to manufacture pre-rolls for some of the biggest names in rock and metal music
Under the terms of the Agreement, Heavy intends to license its Heavy Grass brand for use by Hollister in connection with branding, production and sale of cannabis products primarily via collaborations with its roster of music artists
Hollister will grant to Heavy a limited license for use of its HashBone brand for incorporation into any packaging and/or logo design of products. Heavy will retain ownership of all co-brand designs

VANCOUVER, BC, Aug. 5, 2020 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the “Company”, “Hollister Cannabis Co.” or “Hollister”) a diversified cannabis branding company with products in over 230 dispensaries throughout California, and over 80 dispensaries throughout Arizona, is pleased to announce that it has entered into a letter of intent (the “LOI”) to complete a Definitive Agreement (the “Agreement”) with Heavy Brands Inc. (“Heavy”), a rock and heavy metal lifestyle cannabis branding company.

Under the terms of the Agreement, Heavy intends to license its Heavy Grass brand for use by Hollister in connection with branding, production and sale of cannabis products primarily via collaborations with its roster of music artists. Hollister will grant to Heavy a limited license for use of its HashBone brand for incorporation into any packaging and/or logo design of products. Heavy will retain ownership of all co-brand designs.

Products will be introduced in time and will include separate product branding. Heavy will lead the marketing initiatives of the new products leveraging their unique access to the live music industry.

Heavy-Hollister co-brand products will be distributed exclusively by Hollister’s distribution partner, Indus Holdings Inc. (CSE: INDS), with the first product anticipated to be ready for distribution by October 1, 2020.

When asked about the Agreement, Dez Mitchell, head of Product Development from Heavy shared: “We are so thrilled to begin our partnership with Hollister and cannot wait to launch our first products together this fall. For our Heavy Grass family, music and cannabis go hand in hand. We have been fortunate to get to know Carl and his team over the last year and they have proven to uniquely understand our vision. We are excited to show the world what we’ve been working on together.”

CEO of Hollister Biosciences, Carl Saling, also shared: “Music and cannabis have gone together for so many years; and lately, for the most part, it’s been all connected to rap and hip hop. I have always wanted to bring more attention to cannabis and connect with fans of heavy metal in a truly authentic way.

We have big things in store for our initial launch, and looking forward to many awesome rock and metal collaborations that Hollister and Heavy Grass will be bringing to market.”

About Heavy Brands

Heavy Brands Inc. is a Southern California lifestyle cannabis branding and marketing company building globally recognized cannabis lifestyle brands based in Los Angeles. It’s flagship brand, Heavy Grass, has grown organically by connecting hard rock and heavy metal fans to cannabis products that speak to their lifestyle. Additionally, Heavy Grass releases a seasonal line of apparel that is worn by some of the largest rock artists and fans around the world.

Website: https://getheavy.com/

About Hollister Biosciences Inc.

Website: www.hollistercannabisco.com

ON BEHALF OF THE BOARD

“Carl Saling”

CEO and Director

The CSE does not accept responsibility for the adequacy or accuracy of this release.

The CSE has not in any way passed upon the merits of the Proposed Transaction and has neither approved nor disapproved the contents of this press release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Tags: Cannabis, CBD, CSE, Hemp, small cap, tsx
Posted in Featured, Hollister Biosciences | Comments Off on Hollister Biosciences Inc. $HOLL.ca and Heavy Brands Inc. Enter into Letter of Intent for Proposed Joint Venture Agreement $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Datametrex $DM.ca Awarded Contract Extension With #USAirForce

Posted by AGORACOM-JC at 11:32 AM on Friday, July 31st, 2020

Successfully awarded a second contract in the United States defense industry, United States Air Force via Wright State Applied Research Corp. on July 29, 2020
WSARC is provides contracting, security and research administration services for Wright State Research Institute, the University and the state of Ohio, and will head the U.S. Air Force Academic Partnership and Engagement Experiment (APEX) program

TORONTO, July 31, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G) is pleased to announce that it has been successfully awarded a second contract in the United States defense industry, United States Air Force via Wright State Applied Research Corp. (“WSARC”) on July 29, 2020. WSARC is provides contracting, security and research administration services for Wright State Research Institute, the University and the state of Ohio, and will head the U.S. Air Force Academic Partnership and Engagement Experiment (APEX) program.

“This is a great example of renewable business for Datametrex. Getting a one-year contract extension shows that our technology is valued by the client, and marks progress in our plan to expand our mandate with the organization. Datametrex will continue to solidify our position as a trusted solution provider within the U.S. military departments.” says Marshall Gunter, CEO of the Company.

The contract extension continues with the U.S. Air Force researchers at the Air Force Research Laboratory Airman Systems directorate. The Company is working with researchers within the USAF to land and expand, connecting different groups and finding new stakeholders that can benefit from our A.I. offering. The Air Force Research Laboratory’s Airman Systems Directorate is a vital component of the 711th Human Performance Wing. The directorate is composed of a diverse group of scientists and engineers studying developing technologies specific to the human element of warfighting capability.

The Air Force Research Laboratory (“AFRL”) is leading the discovery, development, and integration of affordable warfighting technologies for the U.S. Air and Space Force. AFRL is a scientific research organization operated by the United States Air Force Materiel Command dedicated to leading the discovery, development, and integrate biological and cognitive technologies to optimize and protect integration of affordable aerospace warfighting technologies, planning and executing the Air Force science and technology program, and providing warfighting capabilities to United States air, space, and cyberspace forces.

For more information on this project or to learn how Datametrex can assist your organization in social media discovery, Fake News Filters and BOT detection, please go to www.nexalogy.com

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: AI, bot, covid19, CSE, datametrex, investments, small cap, tsx
Posted in All Recent Posts, Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Awarded Contract Extension With #USAirForce

ImagineAR $IP.ca $IPNFF Receives Additional $1,000,000 From Exercise Of Warrants For A Total Of Approximately $4.5M In 2020. Launches Moderated Forum On AGORACOM

Posted by AGORACOM-JC at 7:04 AM on Friday, July 31st, 2020

Announced the receipt of approximately $4,571,000 from the exercise of 34,207,000 warrants in 2020 up to July 29, 2020
Company expects to generate meaningful revenue from its current and anticipated sales pipeline over the next 12 months, as well as, receive additional proceeds from further anticipated warrant exercises
Company has also launched a “CEO Verified” Discussion Forum on AGORACOM to serve as the Company’s primary social media platform to interact with both current and prospective shareholders in a fully moderated environment

VANCOUVER, BC and ERIE Pa., July 31, 2020 – ImagineAR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) an Augmented Reality Company that enables sports teams, businesses, retailers and organizations to instantly create their own AR mobile campaigns, is pleased to announce the receipt of approximately $4,571,000 from the exercise of 34,207,000 warrants in 2020 up to July 29, 2020.

Today’s announcement and new total receipts from warrant exercises was preceded by announcements on July 8th, in which the Company announced the receipt of approximately $1,500,000 from the exercise of warrants, followed by an announcement on July 20th of an additional $2,000,000 for a new total of approximately $3,500,000.

FINANCIAL RESOURCES ALLOW IMAGINEAR TO PURSUE ALL AUGMENTED REALITY OPPORTUNITIES

The proceeds from this latest round of warrant exercises is expected to provide ImagineAR with the financial resources necessary to fund growth and operations for a minimum of 30 months, assuming the Company wasn’t able to generate any further revenue from business operations.

However, as the Company expects to generate meaningful revenue from its current and anticipated sales pipeline over the next 12 months, as well as, receive additional proceeds from further anticipated warrant exercises, the Company is confident it now has the war chest necessary to pursue all anticipated business opportunities as the demand for its Augmented Reality solutions continues to grow on a weekly basis.

“Today’s announcement significantly bolsters our financial strength and resources necessary to execute our business plan,” said Paul Silverrstieen, CEO of ImagineAR. “The continued support and confidence of our valued shareholders is deeply appreciated as we aggressively pursue our growth strategy in 2020 and beyond.”

IMAGINEAR LAUNCHES VERIFIED FORUM ON AGORACOM – FIRST ROUND OF Q&A TO BE POSTED TODAY

The Company has also launched a “CEO Verified” Discussion Forum on AGORACOM to serve as the Company’s primary social media platform to interact with both current and prospective shareholders in a fully moderated environment.

AGORACOM Verified Forums provide the first ever identity verification of small cap company executives on an investor platform. As a result, ImagineAR’s CEO and officers can post within a discussion forum without the risk of impersonation, while providing shareholders with the confidence of receiving verified information directly from the Company.

Most importantly, by engaging and communicating in an open forum free for anyone to view, the ImagineAR Verified Forum provides investors will full transparency and equal access to information, without the trolling, profanity and nonsense of unmoderated forums and social media platforms.

Silverrstieen added “Given the growth of the Company in 2020, the demand for engagement and discussion by investors has also grown to the point that it now makes sense to unify these discussions under one umbrella. AGORACOM provides verification of ImagineAR management, as well as, smart rules of engagement to insure civilized, constructive and robust conversation between all of our stakeholders. It will become an invaluable tool given our anticipated developments in 2020 and I look forward to posting our first Q&A later today.”

The ImagineAR Forum can be found at https://agoracom.com/ir/Imaginear/forums/discussion

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

About ImagineAR

ImagineAR Inc. (IP:CSE) (IPNFF:OTCQB) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies. The AR Platform is available as an SDK Plug-in for existing mobile apps.

All trademarks of the property of respective owners.

ON BEHALF OF THE BOARD

Alen Paul Silverrstieen
President & CEO

(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc

We encourage you to do your own due diligence and ask your broker if Imagine AR Inc. (cse: IP) is suitable for your particular investment portfolio*.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by Imagine AR management. Although Imagine AR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Imagine AR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and Imagine AR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Tags: AR, augmented reality, CSE, small cap, stocks, tsx, tsx-v
Posted in Featured, Imagine AR | Comments Off on ImagineAR $IP.ca $IPNFF Receives Additional $1,000,000 From Exercise Of Warrants For A Total Of Approximately $4.5M In 2020. Launches Moderated Forum On AGORACOM

Posts Tagged ‘small cap’

Categories